Andrew Oxtoby
2019
In 2019, Andrew Oxtoby earned a total compensation of $3M as Chief Commercial Officer at Aimmune Therapeutics.
Compensation breakdown
| Bonus | $3,298 |
|---|---|
| Non-Equity Incentive Plan | $169,456 |
| Option Awards | $1,972,710 |
| Salary | $396,667 |
| Stock Awards | $263,280 |
| Other | $145,968 |
| Total | $2,951,379 |
Oxtoby received $2M in option awards, accounting for 67% of the total pay in 2019.
Oxtoby also received $3.3K in bonus, $169.5K in non-equity incentive plan, $396.7K in salary, $263.3K in stock awards and $146K in other compensation.
Rankings
In 2019, Andrew Oxtoby's compensation ranked 4,158th out of 13,971 executives tracked by ExecPay. In other words, Oxtoby earned more than 70.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,158 out of 13,971 | 70th |
Division Manufacturing | 1,514 out of 5,701 | 73rd |
Major group Chemicals And Allied Products | 530 out of 2,200 | 76th |
Industry group Drugs | 446 out of 1,886 | 76th |
Industry Pharmaceutical Preparations | 342 out of 1,398 | 76th |
Source: SEC filing on April 9, 2020.
Oxtoby's colleagues
We found four more compensation records of executives who worked with Andrew Oxtoby at Aimmune Therapeutics in 2019.